David F. Heigener: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Long-Term Safety and Tolerability of Sorafenib in Patients with Advanced Non–Small-Cell Lung Cancer: A Case-Based Review

Alex A. Adjei, George R. Blumenschein Jr., Sumithra Mandrekar, Shauna Hillman, Ulrich Gatzemeier, David Heigener

Journal:

Clinical Lung Cancer

Year:

2011

Language:

english

File:

PDF, 307 KB

english, 2011

2

Book Review - Lung Cancer Therapy Annual 6, Sixth Edition

Heigener, David F

Journal:

Year:

2009

Language:

english

File:

PDF, 203 KB

english, 2009

3

Diagnosis of Malignant Mesothelioma: A Clinical and Pathological Challenge

Kanappilly, Antony, Rabe, Klaus Friedrich, Heigener, David Felix, Stellmacher, Florian, Welker, Lutz

Journal:

Year:

2014

Language:

english

File:

PDF, 18 KB

english, 2014

4

The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)

Gottschling, Sandra, Herpel, Esther, Eberhardt, Wilfried E.E., Heigener, David F., Fischer, Jürgen R., Köhne, Claus-Henning, Kortsik, Cornelius, Kuhnt, Thomas, Muley, Thomas, Meister, Michael, Bischof

Journal:

Year:

2012

Language:

english

File:

PDF, 1.15 MB

english, 2012

5

Immunotherapy: the third wave in lung cancer treatment

Heigener, David Felix, Reck, Martin

Journal:

The Lancet Respiratory Medicine

Year:

2015

Language:

english

File:

PDF, 365 KB

english, 2015

6

Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study

Gottfried, Maya, Bennouna, Jaafar, Bondarenko, Igor, Douillard, Jean-Yves, Heigener, David F., Krzakowski, Maciej, Mellemgaard, Anders, Novello, Silvia, Orlov, Sergei, Summers, Yvonne, von Pawel, Joac

Journal:

Targeted Oncology

Year:

2017

Language:

english

File:

PDF, 1.75 MB

english, 2017

7

Second-line erlotinib in patients with advanced non-small-cell lung cancer: Subgroup analyses from the TRUST study

Heigener, David F., Wu, Yi-Long, van Zandwijk, Nico, Mali, Pekka, Horwood, Keith, Reck, Martin

Journal:

Year:

2011

Language:

english

File:

PDF, 347 KB

english, 2011

8

Frühe palliative Intervention

Eschbach, Corinna, Heigener, David, Nehls, Wiebke, Villalobos, Matthias, van Oorschot, Birgitt

Journal:

Wiener Klinisches Magazin

Year:

2015

Language:

german

File:

PDF, 242 KB

german, 2015

9

Behandlung des nichtkleinzelligen Lungenkarzinoms; Treatment of non-small cell lung cancer;

Heigener, David F., Schiller, Johanna, Reck, Martin

Journal:

Year:

2018

Language:

german

File:

PDF, 650 KB

german, 2018

10

Response to Letter to the Editor

Bischoff, Helge G., Heigener, David F., Walzer, Stefan, Nuijten, Mark

Journal:

Year:

2011

Language:

english

File:

PDF, 46 KB

english, 2011

11

Impact of PD-L1 Expression in EGFR -Positive NSCLC? The Answer Remains the Same…

Heigener, David F., Reck, Martin

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 138 KB

english, 2018

12

Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer

Heigener, David F., von Pawel, Joachim, Eschbach, Corinna, Brune, Andreas, Schmittel, Alexander, Schmelter, Thomas, Reck, Martin, Fischer, Jürgen R.

Journal:

Year:

2013

Language:

english

File:

PDF, 316 KB

english, 2013

13

Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial

Heigener, David F., Pereira, José Rodrigues, Felip, Enriqueta, Mazal, Juraj, Manzyuk, Lyudmila, Tan, Eng Huat, Merimsky, Ofer, Sarholz, Barbara, Esser, Regina, Gatzemeier, Ulrich

Journal:

Targeted Oncology

Year:

2015

Language:

english

File:

PDF, 365 KB

english, 2015

14

Okkulte Fremdkörperaspiration als Differentialdiagnose zum Bronchialka

David Heigener, Peter Lotz, Reyhan Akkan, Jan Fraedrich, Lutz Welker, Ulrich Gatzemeier

Journal:

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Year:

2007

Language:

german

File:

PDF, 200 KB

german, 2007

15

Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinib

David F. Heigener, Martin Reck

Journal:

Advances in Therapy

Year:

2011

Language:

english

File:

PDF, 180 KB

english, 2011

16

Efficacy and safety of bronchoscopic laser therapy in patients with tracheal and bronchial obstruction: a retrospective single institution report

Andreas Hermes, David Heigener, Ulrich Gatzemeier, Joachim Schatz, Martin Reck

Journal:

The Clinical Respiratory Journal

Year:

2012

Language:

english

File:

PDF, 459 KB

english, 2012

17

Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer: Final Results of a Randomized Phase III Trial

Fink, Thomas H., Huber, Rudolf M., Heigener, David F., Eschbach, Corrina, Waller, Cornelius, Steinhauer, Ernst U., Virchow, Johann C., Eberhardt, Frank, Schweisfurth, Hans, Schroeder, Michael, Ittel,

Journal:

Journal of Thoracic Oncology

Year:

2012

Language:

english

File:

PDF, 1.14 MB

english, 2012

18

Reviewing the safety of erlotinib in non-small cell lung cancer

Reck, Martin, Mok, Tony, Wolf, Jürgen, Heigener, David, Wu, Yi-long

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 383 KB

english, 2011

19

Lung cancer in 2017: Giant steps and stumbling blocks

Heigener, David F., Reck, Martin

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Year:

2017

Language:

english

File:

PDF, 161 KB

english, 2017

20

Management of non-small-cell lung cancer: recent developments

Reck, Martin, Heigener, David F, Mok, Tony, Soria, Jean-Charles, Rabe, Klaus F

Journal:

Year:

2013

Language:

english

File:

PDF, 406 KB

english, 2013

21

Immunotherapy for small-cell lung cancer: emerging evidence

Reck, Martin, Heigener, David, Reinmuth, Niels

Journal:

Future Oncology

Year:

2016

Language:

english

File:

PDF, 2.14 MB

english, 2016

22

Redefining treatment paradigms in first-line advanced non-small cell lung cancer

Heigener, David F, Kerr, Keith M, Laing, Gavin M, Mok, Tony S.K., Moiseyenko, Fedor V, Reck, Martin

Journal:

Clinical Cancer Research

Year:

2019

File:

PDF, 1.37 MB

2019

23

Targeting of MEK in lung cancer therapeutics

Heigener, David F, Gandara, David R, Reck, Martin

Journal:

The Lancet Respiratory Medicine

Year:

2015

Language:

english

File:

PDF, 1.20 MB

english, 2015

24

Non-Small Cell Lung Cancer in Never-Smokers: A New Disease Entity?

Heigener, David F.

Journal:

Year:

2011

Language:

english

File:

PDF, 178 KB

english, 2011

25

Epidermal Growth Factor Receptor-Related Tumor Markers and Clinical Outcomes with Erlotinib in Non-small Cell Lung Cancer: An Analysis of Patients from German Centers in the TRUST Study

Schneider, Claus-Peter, Heigener, David, Schott-von-Römer, Kathrin, Gütz, Sylvia, Laack, Eckart, Digel, Werner, Guschall, Wolf-Rüdiger, Franke, Andreas, Bodenstein, Heinrich, Schmidtgen, Claudia, Reck

Journal:

Journal of Thoracic Oncology

Year:

2008

Language:

english

File:

PDF, 661 KB

english, 2008

26

Single-Agent Pemetrexed for Chemonaïve and Pretreated Patients with Malignant Pleural Mesothelioma: Results of an International Expanded Access Program

Taylor, Paul, Castagneto, Bruno, Dark, Graham, Marangolo, Maurizio, Scagliotti, Giorgio V., van Klaveren, Rob J., Labianca, Roberto, Serke, Monika, Schuette, W, van Meerbeeck, Jan P., Heigener, David,

Journal:

Journal of Thoracic Oncology

Year:

2008

Language:

english

File:

PDF, 363 KB

english, 2008

27

Chemotherapie beim älteren Patienten mit nicht kleinzelligem Lungenkarzinom: Eine nicht-interventionelle, prospektive, multizentrische Beobachtungsstudie

Heigener, David, Hoeffken, Gert, Wuerflein, Dieter, Feurer, Matthias, Rittmeyer, Achim, Huber, Roland, Pietsch, Markus, Ring, Arne, Deppermann, Karl-Matthias

Journal:

DMW - Deutsche Medizinische Wochenschrift

Year:

2017

Language:

german

File:

PDF, 528 KB

german, 2017

28

Measurement of quality of life in second-line patients with advanced NSCLC without targetable mutations: a review

Heigener, David, Küchler, Thomas

Journal:

Lung Cancer Management

Year:

2016

Language:

english

File:

PDF, 2.21 MB

english, 2016

29

Redefining treatment paradigms in first-line advanced non-small cell lung cancer

Heigener, David F, Kerr, Keith M, Laing, Gavin M, Mok, Tony S.K., Moiseyenko, Fedor V, Reck, Martin

Journal:

Clinical Cancer Research

Year:

2019

Language:

english

File:

PDF, 1.37 MB

english, 2019

30

Tyrosinkinaseinhibitoren beim nichtkleinzelligen Lungenkarzinom

David F. Heigener

Journal:

Year:

2009

Language:

german

File:

PDF, 267 KB

german, 2009

31

A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer

Nuijten, Mark J.C., de Castro Carpeño, Javier, Chouaid, Christos, Vergnenègre, Alain, Grossi, Francesco, Bischoff, Helge, Heigener, David, Walzer, Stefan

Journal:

Year:

2012

Language:

english

File:

PDF, 375 KB

english, 2012

32

Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer

Nuijten, Mark, Heigener, David F., Bischoff, Helge G., Chouaid, Christos, Vergnenègre, Alain, de Castro Carpeño, Javier, Aultman, Rick, Walzer, Stefan, Siebert, Uwe

Journal:

Year:

2010

Language:

english

File:

PDF, 145 KB

english, 2010

33

Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study

Reck, Martin, Frickhofen, Norbert, Cedres, Susana, Gatzemeier, Ulrich, Heigener, David, Fuhr, Heinz-Georg, Thall, Aron, Lanzalone, Silvana, Stephenson, Patricia, Ruiz-Garcia, Ana, Chao, Richard, Felip

Journal:

Year:

2010

Language:

english

File:

PDF, 210 KB

english, 2010

34

Novel angiogenesis inhibitors in nonsmall cell lung cancer

Reinmuth, Niels, Heigener, David, Reck, Martin

Journal:

Current Opinion in Oncology

Year:

2015

Language:

english

File:

PDF, 224 KB

english, 2015

35

Nintedanib for the treatment of patients with advanced non-small-cell lung cancer

Reck, Martin, Heigener, David, Reinmuth, Niels

Journal:

Expert Review of Clinical Pharmacology

Year:

2014

Language:

english

File:

PDF, 494 KB

english, 2014

36

Immune checkpoint blockade in small cell lung cancer

Tay, Rebecca Y., Heigener, David, Reck, Martin, Califano, Raffaele

Journal:

Year:

2019

Language:

english

File:

PDF, 2.01 MB

english, 2019

37

PD-1 Axis Inhibition in EGFR Positives: A Blunt Sword?

Heigener, David F., Reck, Martin

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 143 KB

english, 2017

38

Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study

Reck, Martin, van Zandwijk, Nico, Gridelli, Cesare, Baliko, Zoltan, Rischin, Danny, Allan, Simon, Krzakowski, Maciej, Heigener, David

Journal:

Journal of Thoracic Oncology

Year:

2010

Language:

english

File:

PDF, 211 KB

english, 2010

39

Diagnostics and staging procedures in non-small cell lung cancer – is less more?

David Felix Heigener, Klaus-Dieter Diemel, Martin Reck, Ulrich Gatzemeier

Journal:

The Clinical Respiratory Journal

Year:

2008

Language:

english

File:

PDF, 188 KB

english, 2008

40

Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany

Bischoff, Helge G., Heigener, David F., Walzer, Stefan, Nuijten, Mark

Journal:

Year:

2010

Language:

english

File:

PDF, 129 KB

english, 2010

41

First- and second-line treatment of non-small-cell lung cancer patients with EGFR mutation-positive tumors

Reck, Martin, Reinmuth, Niels, Heigener, David F

Journal:

Lung Cancer Management

Year:

2012

Language:

english

File:

PDF, 1.85 MB

english, 2012

42

Second-line treatment selection in patients with non-small cell lung cancer of adenocarcinoma histology: findings from a European survey of treating physicians

Girard, Nicolas, Corral, Jesus, Cortinovis, Diego, Heigener, David F.

Journal:

Clinical Lung Cancer

Year:

2016

Language:

english

File:

PDF, 2.22 MB

english, 2016

43

Societal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC)

Stanisic, Sanja, Bischoff, Helge G., Heigener, David F., Vergnenègre, Alain, de Castro Carpeño, Javier, Chouaid, Christos, Walzer, Stefan, Mueller, Elvira, Schmidt, Elvira

Journal:

Year:

2010

Language:

english

File:

PDF, 197 KB

english, 2010

44

Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer

Heigener, David, Reck, Martin

Journal:

Expert Review of Anticancer Therapy

Year:

2015

Language:

english

File:

PDF, 807 KB

english, 2015

45

Multicenter Randomized Open-Label Phase III Study Comparing Efficacy, Safety, and Tolerability of Conventional Carboplatin Plus Etoposide Versus Dose-Intensified Carboplatin Plus Etoposide Plus Lenograstim in Small-Cell Lung Cancer in “Extensive Disease” Stage

Heigener, David Felix, Manegold, Christian, Jäger, Elke, Saal, Johannes-Georg, Zuna, Ivan, Gatzemeier, Ulrich

Journal:

American Journal of Clinical Oncology

Year:

2009

Language:

english

File:

PDF, 362 KB

english, 2009

46

Nichtkleinzelliges Lungenkarzinom – Diagnostik und stadienadaptierte Therapie

David F. Heigener, Martin Reck, Ulrich Gatzemeier

Journal:

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Year:

2007

Language:

german

File:

PDF, 438 KB

german, 2007

47

Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” [Lung Cancer 69S1 (2010) S4–S10]

Nuijten, Mark, Heigener, David F., Bischoff, Helge G., Chouaid, Christos, Vergnenègre, Alain, de Castro Carpeño, Javier, Aultman, Rick, Walzer, Stefan, Siebert, Uwe

Journal:

Year:

2010

Language:

english

File:

PDF, 78 KB

english, 2010

48

Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Langer, Corey J., O’Byrne, Kenneth J., Socinski, Mark A., Mikhailov, Sergei M., Leśniewski-Kmak, Krzysztof, Smakal, Martin, Ciuleanu, Tudor E., Orlov, Sergey V., Dediu, Mircea, Heigener, David, Eisenf

Journal:

Journal of Thoracic Oncology

Year:

2008

Language:

english

File:

PDF, 304 KB

english, 2008

49

Incidence of Febrile Neutropenia and Myelotoxicity of Chemotherapy: A Meta-Analysis of Biosimilar G-CSF Studies in Breast Cancer, Lung Cancer, and Non-Hodgkin’s Lymphoma

Engert, Andreas, del Giglio, Auro, Bias, Peter, Lubenau, Heinz, Gatzemeier, Ulrich, Heigener, David

Journal:

Year:

2009

File:

PDF, 126 KB

2009

50

A comparison of the estimated costs of erlotinib, docetaxel and pemetrexed for the second-line treatment of non-small cell lung cancer from the German healthcare perspective

Kotowa, Wioletta, Gatzemeier, Ulrich, Pirk, Olaf, Gabriel, Anja, Heigener, David

Journal:

Journal of Medical Economics

Year:

2007

Language:

english

File:

PDF, 734 KB

english, 2007

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски